Balyasny Asset Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Balyasny Asset Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-486,971	Closed	-$10.4M	–	3250
2024 Q1	$10.4M	Buy	+486,971	New	+$5.82M	0.02%	907

Balyasny Asset Management's FUSN Position: Q2 2024 in Review

Balyasny Asset Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 486,971 shares — an estimated $10.4M sold.

Balyasny Asset Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $10.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Balyasny Asset Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Balyasny Asset Management sold 486,971 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $10.4M.
Balyasny Asset Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Balyasny Asset Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $10.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.